Corbus Pharmaceuticals Holdings, Inc. (CRBP) › Shareholders' EquityCorbus Pharmaceuticals Holdings, Inc. (CRBP) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2013: -$1.78M2014: $5.86M2015: $8.99M2016: $8.92M2017: $57.78M2018: $27.52M2019: $6.16M2020: $45.27M2021: $69.11M2022: $32.99M2023: -$6.91M2024: $142.43M2025: $147.50M$147.50M2013Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$147.50M+3.6%2024$142.43M+2162.7%2023-$6.91M-120.9%2022$32.99M-52.3%2021$69.11M+52.6%2020$45.27M+635.3%2019$6.16M-77.6%2018$27.52M-52.4%2017$57.78M+547.9%2016$8.92M-0.7%2015$8.99M+53.3%2014$5.86M+428.8%2013-$1.78M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share